Clinical Trials Logo
  1. Home
  2. Kidney Diseases
  3. NCT03303222
  4. Details
NCT03303222 Clinical Trial

Study to Develop a Breath Analyser to Detect Chronic Kidney Disease

Kidney Diseases Clinical Trial

Official title:
Pilot Study to Develop a Breath Analyser to Detect Chronic Kidney Disease

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03303222
Other study ID # IRAS 228416
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 10, 2021
Est. completion date November 30, 2023

Study information
Verified date November 2020
Source University College, London
Contact andrew davenport, md
Phone 442077940500
Email andrewdavenport@nhs.net
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Measure trimethylamine oxide in the breath.

Description:

Organic compounds such as trimethylamine oxide (TMAO) accumulate in the blood of patients with kidney disease, and volatile compounds such as TMAO can be detected in the breath. The investigators wish to develop a breath analyser to measure volatile compounds, such as TMAO in the breath in patients with kidney disease.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 100
Est. completion date November 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - patients with kidney disease under the care of Royal Free Hospital Exclusion Criteria: - patients unable to provide informed consent - patients unable to exhale into breath analyser

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• breath
measurement of volatile compounds, such as TMAO in exhaled breath and blood

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University College, London

Outcome
Type Measure Description Time frame Safety issue
Primary measurement of breath TMAO measurement of breath TMAO by breath analyser 3 years
See also
  Status Clinical Trial Phase
Completed NCT03246984 - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ N/A
Completed NCT03545113 - Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease N/A
Recruiting NCT05100017 - Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure N/A
Recruiting NCT04559321 - Holmium Vs Trilogy Kidney Stones GUY's 1-2 Phase 3
Recruiting NCT05036850 - China Kidney Patient Trials Network
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Active, not recruiting NCT01529658 - Renal Hypothermia During Partial Nephrectomy N/A
Completed NCT01679587 - Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD) Phase 1
Completed NCT01155141 - Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH Phase 4
Completed NCT00755690 - Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease N/A
Recruiting NCT05759754 - Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease N/A
Completed NCT03213158 - Ixazomib for Desensitization Phase 2
Active, not recruiting NCT02237352 - Mechanisms of Diabetic Nephropathy in Ecuador
Recruiting NCT06067867 - Kidney and Pregnancy Registry
Recruiting NCT04110080 - Enhanced Recovery After Surgery in Kidney Transplant Donors N/A
Active, not recruiting NCT04876963 - HOLT-ED: Holter-monitoring in End-stage Renal Disease
Enrolling by invitation NCT05324878 - Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Active, not recruiting NCT04631965 - Healthcare Transition of Adolescents With Chronic Health Conditions
Completed NCT03394859 - Electronic Medical Records and Genomics (eMERGE) Phase III